简体中文
|
繁體中文
|
English
Business Wire Global sites
Business Wire Global
UK/Ireland
Deutschland
France
Italy
Japan
Home
News
Events
Media Services
About Us
Contact Us
Health and Pharmaceutical Press Releases
2024-06-03 09:51
Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
2024-05-31 16:31
Morinaga Milk’s New Research Breakthrough Backed the Superiority of its Human-Residential Bifidobacteria (HRB) Strains in Metabolizing Toxin Precursor in the Gut
2024-05-31 15:18
Quit Like Sweden Urges Progressive Tobacco Control to Save Millions of Lives on World No Tobacco Day
2024-05-31 11:00
Parse Biosciences Launches Trailmaker Data Analysis Platform to Simplify Single Cell Sequencing
2024-05-31 10:00
Rhea Launches with Senior Advisory Panel, Growth Acquisitions and Strategic Partnerships to Advance Fertility Journeys for the Modern Family
2024-05-30 10:25
Asymchem Welcomes Franck Mevellec as Senior Director, Business Development
2024-05-30 10:00
We Are Innovation and Anglo-American University Hosted the Exclusive Premiere of "How Sweden Quit Smoking"
2024-05-30 09:47
JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)
2024-05-29 22:43
Bio-Sourcing and Partners Launch €3.4M EU Project in Inflammatory Indications with €1.9M EUREKA Eurostars Subsidies
2024-05-29 10:26
Kolmar BNH Expands Its Global Market by Launching HemoHIM G in Taiwan
2024-05-29 10:12
TVM Capital Healthcare Announces the Closing of its Saudi Arabia-Focused TVM Healthcare Afiyah Fund
2024-05-28 10:59
Datopotamab deruxtecan showed clinically meaningful overall survival improvement vs. chemotherapy in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial
2024-05-27 10:45
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
2024-05-24 15:47
Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe
2024-05-24 10:50
Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
2024-05-24 09:40
Veristat Appoints New Chief Commercial Officer
2024-05-23 13:10
Galderma Launches Restylane® VOLYME™ in China – One of the World’s Fastest Growing Aesthetics Markets
2024-05-22 16:13
Medscape Education and KDIGO Nephrology Collaboration Accelerates Improvements to Patient Care
2024-05-22 14:10
QPS Expands Clinic in Miami, Florida to Accommodate Increasing Demand for Obesity Trials
2024-05-22 13:00
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
<< First
< Previous
14
15
16
17
18
19
20
21
22
23
Next >
Last >>
56942
56938
56937
56935
56924
56916
56912
56910
56907
56901
56898
56888
56883
56877
56873
56866
56862
56858
56855
56854
Business Wire Weibo
Press Releases
Corporate Social Responsibility
Manufacturing
Chemical
Health and Pharmaceutical
Property
Travel
Automotive
Life and Entertainment
Energy and Environmental
Retail
Transportation
Business and E-commerce
Communications and Media
Metals and Mining
Finance
Technology
Sports
Education
Art and Culture
Legal
Latest Releases
2025-04-25 15:55
Mantle Index Four (MI4) Fund Launches with Securitize as Tokenization Partner and Mantle Treasury as Anchor Investor
2025-04-25 15:50
Boomi World 2025: Accelerating What’s Next in AI, Integration, and the Connected Enterprise
2025-04-25 15:42
UPS to Acquire Andlauer Healthcare Group for $1.6 Billion, Strengthening its Global Offerings in Complex Healthcare Logistics
2025-04-25 15:39
Diligent Unveils AI Risk Essentials to Accelerate Risk Management and Elevate Governance
2025-04-25 11:57
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea